We've appointed leading pharmaceutical industry expert Dr Arthur Roach as our new Director of Research and Development, to provide leadership to our growing research programme.
Arthur brings over 25 years' experience directing research in Parkinson's.
Arthur brings over 25 years' experience directing research in Parkinson's and other neurodegenerative conditions at universities, hospitals, and pharmaceutical and biotechnology companies around the world.
He'll be leading our research programme, which currently totals £20m and spans 90 research projects both in the UK and internationally.
Steve Ford, our Chief Executive, says:
"We've had a hand in an array of fantastic advances in Parkinson's research in recent years but we still haven't cracked the holy grail of Parkinson's research – a cure.
"Arthur's industry background will put fire under our portfolio, focusing our efforts on only the most promising research that has the potential to transform the lives of people living with Parkinson's."
Arthur brings a fresh perspective, having previously held positions at Chord Therapeutics and Merck Serono developing Parkinson's treatments for the market.
I believe we're on the cusp of finally finding ways to slow or stop the progression of Parkinson's.
"There's never been a more exciting time in Parkinson's research.
"With recent breakthroughs in genetics, I believe we're on the cusp of finally finding ways to slow or stop the progression of Parkinson's, something which no current treatment can do."
"Parkinson's UK is in a unique position to ignite collaboration between researchers, companies, doctors and people with Parkinson's across the globe, so they can work as a superpower to find a cure for Parkinson's."